Press Releases
Notal Vision, an Israeli-based
medical device company, has selected
ClinicalAnalytics 4.0 (CA) for a
Phase II device trial that will occur
in Israel and the United States. Download PDF
Peter O’Blenis to Speak at the
International Society for
Pharmacoeconomics and Outcomes Research
(ISPOR) Conference in Seoul, South
Korea, Sept. 7-9. Download PDF
TrialStat Corporation recently added
Innovaderm Research Inc. to the
growing list of CROs joining
TrialStat's CROFirst program. Download PDF
TrialStat Corporation announces its
enhanced pricing options for customers
using its ClinicalAnalytics 4.0 EDC
solution. Download PDF
TrialStat Corporation added Kriger
Research Group International, a
worldwide CRO to its enhanced CROFirst
Program. Download PDF
TrialStat Corporation added SMS-
oncology, an Amsterdam-based CRO
specializing in oncology, to its
enhanced CROFirst Program. Download PDF
TrialStat made enhancements to its
CROFirst Program to reward the
company’s CRO customers in North
America and Europe for participating
in
joint business development and
marketing of CA 4.0 to the industry. Download PDF
